BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 14602715)

  • 1. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts.
    Monaghan E; Gueorguiev V; Wilkins-Port C; McKeown-Longo PJ
    J Biol Chem; 2004 Jan; 279(2):1400-7. PubMed ID: 14602715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
    Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
    J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts.
    Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA
    J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor.
    Monaghan-Benson E; McKeown-Longo PJ
    J Biol Chem; 2006 Apr; 281(14):9450-9. PubMed ID: 16461772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
    Aguirre Ghiso JA; Kovalski K; Ossowski L
    J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.
    Aguirre-Ghiso JA; Liu D; Mignatti A; Kovalski K; Ossowski L
    Mol Biol Cell; 2001 Apr; 12(4):863-79. PubMed ID: 11294892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T; Andronicos N; Czekay RP; Mazar AP; Bdeir K; Parry GC; Kuo A; Loskutoff DJ; Cines DB; Takada Y
    J Biol Chem; 2003 Aug; 278(32):29863-72. PubMed ID: 12754207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.
    Wei Y; Tang CH; Kim Y; Robillard L; Zhang F; Kugler MC; Chapman HA
    J Biol Chem; 2007 Feb; 282(6):3929-39. PubMed ID: 17145753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.
    Akimov SS; Belkin AM
    J Cell Sci; 2001 Aug; 114(Pt 16):2989-3000. PubMed ID: 11686302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
    Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.
    Czekay RP; Aertgeerts K; Curriden SA; Loskutoff DJ
    J Cell Biol; 2003 Mar; 160(5):781-91. PubMed ID: 12615913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
    Planus E; Barlovatz-Meimon G; Rogers RA; Bonavaud S; Ingber DE; Wang N
    J Cell Sci; 1997 May; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of integrin function by the urokinase receptor.
    Wei Y; Lukashev M; Simon DI; Bodary SC; Rosenberg S; Doyle MV; Chapman HA
    Science; 1996 Sep; 273(5281):1551-5. PubMed ID: 8703217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.
    Bass R; Werner F; Odintsova E; Sugiura T; Berditchevski F; Ellis V
    J Biol Chem; 2005 Apr; 280(15):14811-8. PubMed ID: 15677461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator inhibits alpha 4 beta 1 integrin-mediated T lymphocyte adhesion to fibronectin independently of its catalytic activity.
    Olivier P; Bieler G; Müller KM; Hauzenberger D; Rüegg C
    Eur J Immunol; 1999 Oct; 29(10):3196-209. PubMed ID: 10540331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the alphavbeta5 and alpha5beta1 integrins.
    Vial D; McKeown-Longo PJ
    J Cell Sci; 2008 May; 121(Pt 10):1661-70. PubMed ID: 18445685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role for the integrin-binding III-10 module in fibronectin matrix assembly.
    Hocking DC; Smith RK; McKeown-Longo PJ
    J Cell Biol; 1996 Apr; 133(2):431-44. PubMed ID: 8609174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.